Benzinga's Top Analyst Calls From April 10, 2018

• Maxim raises BeiGene Ltd BGNE price target from $160 to $200; Says the company continues to advance its clinical pipeline with multiple catalysts ahead and a strong balance sheet with runway well into 2020.
• B. Riley out defending Spectrum Pharmaceuticals, Inc. SPPI, expects shares to rebound as poziotinib represents 'a potential exciting new treatment for NSCLC patients'; Believes Spectrum is moving towards a U.S. breakthrough therapy filing.
• Morgan Stanley raises Seagate Technology PLC STC price target from $51 to $72 implying 28 percent upside. Says market is “underappreciating the money behind the growth in data storage.”
• Goldman Sachs downgrades Cognex Corporation CGNX, says 2018 is a “transition year” for the company and opex growth will put pressure on margins.
• Morgan Stanley upgrades NVIDIA Corporation NVDA from Equal-Weight to Overweight; Says data era now “Investable”and machine learning inference will be a “very important” market.
• Raymond James raises Netflix, Inc. NFLX price target from $290 to $330. While presence of the World Cup may affect Q2 guidance, firm says the company’s “core thesis” remains intact due to global market share gains, pricing power and margin expansion.
• Deutsche Bank maintains Buy rating on Philip Morris International PM; “Potentially heightened cash returns will form part of management's agenda in our view."

See Also:

Benzinga's Top Upgrades, Downgrades For April 10, 2018

7 Biggest Price Target Changes For Tuesday